Heart failure & cardiomyopathies

Effect of Pulmonary Artery Pressure-Guided Management on Outcomes of Patients with Heart Failure Outside Clinical Trials: A Systematic Review and Meta-Analysis of Real-World Evidence with the CardioMEMS Heart Failure System

Eur J Heart FailPublished Systematic review and meta-analysis of observational (non-RCT) studies

Pooled result · HFHResult — go to the resultIncidence rate ratio 0.39 CI 0.31–0.47

Authors' conclusion

Heart failure management with CardioMEMS leads to lower PAP, improved functional status and quality of life, and decrease of HFHs at 1 year in patients receiving the device in a real-life, non-RCT setting.

Study context

Population
Adults with heart failure (HF) receiving CardioMEMS in a non-RCT setting
Participants
3,306 adults8 studies
Comparison
Pulmonary artery pressure (PAP)-guided HF management with CardioMEMS: after vs before implantation
Outcome
HF hospitalization (HFH) rates
Follow-up
1 year
Methodological detailspre/post comparison, random-effects models, 4 US, 4 European studies, 4 single-arm, open-label industry studies and 4 real-world practice studies
  • Pre/post comparison
  • Random-effects models
  • 4 US, 4 European studies
  • 4 single-arm, open-label industry studies and 4 real-world practice studies

Pooled result

HFH

Incidence rate ratio

0.39

CI 0.31–0.47

CardioMEMSvs Pre-implantation
IRR 0.39 (CI 0.31–0.47)

As reported in the abstract

Further pooled results

Change in PAP

Significant decrease in systolic PAP
−7.8 mmHg [−10.1 mmHg; −5.6 mmHg]
Significant decrease in mean PAP
−5.2 mmHg [−6.7 mmHg; −3.8 mmHg]
Significant decrease in diastolic PAP
−4.4 mmHg [−5.5 mmHg; −3.3 mmHg]
  • Random-effect models

New York Heart Association (NYHA) class I/II · 1 year after implantation

Patients in NYHA class I/II
56% [43%; 67%]

EQ-5D-5L visual analogue scale · 1 year after implantation

Significant improvement from baseline
7.2 [3.5; 10.9]

Original publication

Effect of Pulmonary Artery Pressure-Guided Management on Outcomes of Patients with Heart Failure Outside Clinical Trials: A Systematic Review and Meta-Analysis of Real-World Evidence with the CardioMEMS Heart Failure System. Eur J Heart Fail. Published 13 May 2025. doi:10.1002/ejhf.3687

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.